Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
Biopharma company Immuron (IMC) has received U.S. Food and Drug Administration (FDA) guidance for a new investigational drug designed to treat diarrhoea. The drug is…
By Pharmatrax Author
Category: News
No Comments
The discovery of new biomarkers other than amyloid or tau is an optimistic sign for Alzheimer’s drug development, according to an expert on clinical research…
By Pharmatrax Author
Category: Technoloy
No Comments
The US Food and Drug Administration (FDA) on Wednesday finalized two guidances on developing drugs to treat community-acquired or hospital-acquired and ventilator-associated bacterial pneumonia. Both…
By Pharmatrax Author
Category: Technoloy
No Comments
Bayer AG, the German pharma giant, has signed a collaboration agreement to test out new drugs on human heart tissue 3D-printed by researchers at Tel…
By Pharmatrax Author
Category: Technoloy
No Comments
Pharmaceutical company Apotex Inc. is recalling some of its diabetes medication after some was found to have elevated levels of a contaminant which has been…
By Pharmatrax Author
Category: Technoloy
No Comments
According to a report published last year, the cost of finding a new medicine is a whopping $2.5 billion, which is up from $1.8 billion in 2010. A…
By Pharmatrax Author
Category: Technoloy
No Comments
“It all started in the 1950s with the famous mathematician Alan Turing, who asked the question – can machines think?” – Pieter Peeters, Janssen Research…
By Pharmatrax Author
Category: Technoloy
No Comments
Artificial intelligence can make drug discovery and development faster and less risky according to an industry expert, who said understanding complex diseases at the genetic…
By Pharmatrax Author
Category: News
No Comments
Researchers from Egypt, India, and the UK are studying the role of 3D printing in drug delivery systems. Their findings are detailed in the recently…
By Pharmatrax Author
Category: Technoloy
No Comments
insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C…